News & Currents - Westchester HealthFDA Issues Warning on Counterfeit Surgical MeshMarch 11, 2010, 5:39 am by FDA News ReleasesThe U.S. Food and Drug Administration today warned health care providers and consumers about counterfeit surgical mesh being distributed in the United States under the C. R. Bard/Davol brand name. Surgical mesh products are used to reinforce soft tissue where weakness exists.
More from FDA News Releases FDA and industry reach agreement in principle on medical device user fees FDA News Releases: February 1, 2012, 9:48 am The FDA and representatives from the medical device industry have reached an agreement in principle on proposed recommendations for the third reauthorization of a medical device user fee program. The recommendations would FDA approves Kalydeco to treat rare form of cystic fibrosis FDA News Releases: January 31, 2012, 10:59 am The U.S. Food and Drug Administration today approved Kalydeco (ivacaftor) for the treatment of a rare form of cystic fibrosis (CF) in patients ages 6 years and older who have the specific FDA takes action against New York cheese manufacturer FDA News Releases: January 31, 2012, 10:13 am The U.S. Food and Drug Administration is asking a federal court to prevent a New York cheese manufacturer from operating because of a history of unsanitary conditions and producing cheese in a FDA approves Gleevec for expanded use in patients with rare gastrointestinal cancer FDA News Releases: January 31, 2012, 5:29 am The U.S. Food and Drug Administration today granted Gleevec (imatinib) regular approval for use in adult patients following surgical removal of CD117-positive gastrointestinal stromal tumors (GIST). Today’s action also highlights an increase FDA approves new treatment for most common type of skin cancer FDA News Releases: January 30, 2012, 10:58 am Today, Erivedge (vismodegib) was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The drug is intended for |
|
|
